Stomach emptying and epilepsy drug study
Part of Brain & nervous system clinical trials.
This study uses a bedside ultrasound to see how epilepsy and seizure medications affect stomach emptying before surgery. It aims to help doctors understand if current fasting rules are safe for people with epilepsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of epilepsy confirmed by your doctor or medical history.
- You are scheduled for surgery under anesthesia, either for epilepsy or another reason.
- You are at least 18 years old.
- You are able to follow standard fasting instructions before surgery.
- You are not pregnant, do not have certain stomach motility problems, and are not taking prokinetic medications like Metoclopramide or Erythromycin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an ultrasound to look at how full your stomach is after taking GLP-1 medications for diabetes or weight loss. It will help doctors understand if current fasting guidelines are safe before surgery or a colonoscopy.
This study uses ultrasound to see how quickly your stomach empties after a meal. It aims to learn more about normal stomach function in healthy adults.
This study uses ultrasound to measure how much stomach content remains after fasting in people who have had sleeve gastrectomy surgery. It aims to understand if the standard 8-hour fasting period is enough for this group before other surgeries.
This trial uses a stomach ultrasound (called gastric POCUS) to check if your stomach is empty before surgery. It is for patients taking GLP-1 medications (like Ozempic, Wegovy, or similar) to help make sure it is safe to proceed with anesthesia.
This study looks at whether a common diabetes medication (GLP-1) affects how much food stays in your stomach before surgery. It aims to make anesthesia safer by understanding stomach content.
This trial looks at how starting a GLP-1 medicine affects the amount of food left in your stomach and how quickly your stomach empties. It may help doctors better understand how these medicines work and how to use them safely.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.